These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20539322)

  • 1. Role of cell surface molecules and autologous ascitic fluid in determining efficiency of adenoviral transduction of ovarian cancer cells.
    Ingram N; MacCormac LP; Oxley NT; Burns PA; Hall GD
    Cancer Gene Ther; 2010 Oct; 17(10):684-93. PubMed ID: 20539322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression.
    You Z; Fischer DC; Tong X; Hasenburg A; Aguilar-Cordova E; Kieback DG
    Cancer Gene Ther; 2001 Mar; 8(3):168-75. PubMed ID: 11332987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.
    Brüning A; Köhler T; Quist S; Wang-Gohrke S; Moebus VJ; Kreienberg R; Runnebaum IB
    Hum Gene Ther; 2001 Mar; 12(4):391-9. PubMed ID: 11242531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.
    Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT
    Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta.
    Brüning A; Runnebaum IB
    Gene Ther; 2003 Feb; 10(3):198-205. PubMed ID: 12571626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro.
    Kelly FJ; Miller CR; Buchsbaum DJ; Gomez-Navarro J; Barnes MN; Alvarez RD; Curiel DT
    Clin Cancer Res; 2000 Nov; 6(11):4323-33. PubMed ID: 11106250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the adenoviral sensitivity of human ovarian cancer cells by transient expression of coxsackievirus and adenovirus receptor (CAR).
    Kim JS; Lee SH; Cho YS; Choi JJ; Kim YH; Lee JH
    Gynecol Oncol; 2002 May; 85(2):260-5. PubMed ID: 11972385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coxsackie adenovirus receptor and alpha nu beta3/alpha nu beta5 integrins in adenovirus gene transfer of rat cochlea.
    Venail F; Wang J; Ruel J; Ballana E; Rebillard G; Eybalin M; Arbones M; Bosch A; Puel JL
    Gene Ther; 2007 Jan; 14(1):30-7. PubMed ID: 16886000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
    Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated thymidine kinase gene therapy and coxsackie adenovirus receptor expression in ovarian cancer cells.
    Kieback DG
    Cancer Genomics Proteomics; 2008; 5(6):311-8. PubMed ID: 19287072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy.
    Lam JT; Kanerva A; Bauerschmitz GJ; Takayama K; Suzuki K; Yamamoto M; Bhoola SM; Liu B; Wang M; Barnes MN; Alvarez RD; Siegal GP; Curiel DT; Hemminki A
    J Gene Med; 2004 Dec; 6(12):1333-42. PubMed ID: 15493039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.
    Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
    Int J Oncol; 2008 Dec; 33(6):1141-7. PubMed ID: 19020746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
    Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W
    Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
    Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A
    Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
    Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
    Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses.
    Hakkarainen T; Hemminki A; Pereboev AV; Barker SD; Asiedu CK; Strong TV; Kanerva A; Wahlfors J; Curiel DT
    Clin Cancer Res; 2003 Feb; 9(2):619-24. PubMed ID: 12576427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
    Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
    Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas.
    Zeimet AG; Müller-Holzner E; Schuler A; Hartung G; Berger J; Hermann M; Widschwendter M; Bergelson JM; Marth C
    Gene Ther; 2002 Aug; 9(16):1093-100. PubMed ID: 12140737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.